FIXX
Price:
$0.9347
Market Cap:
$3.02M
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in ...[Read more]
Industry
Biotechnology
IPO Date
2018-03-28
Stock Exchange
NASDAQ
Ticker
FIXX
According to Homology Medicines, Inc.’s latest financial reports and current stock price. The company's current ROE is -100.91%. This represents a change of 365.64% compared to the average of -21.67% of the last 4 quarters.
The mean historical ROE of Homology Medicines, Inc. over the last ten years is -36.51%. The current -100.91% ROE has changed 176.38% with respect to the historical average. Over the past ten years (40 quarters), FIXX's ROE was at its highest in in the March 2022 quarter at 34.59%. The ROE was at its lowest in in the September 2023 quarter at -37.36%.
Average
-36.51%
Median
-34.19%
Minimum
-154.76%
Maximum
81.35%
Discovering the peaks and valleys of Homology Medicines, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 71.29%
Maximum Annual ROE = 81.35%
Minimum Annual Increase = -57126.72%
Minimum Annual ROE = -154.76%
Year | ROE | Change |
---|---|---|
2023 | -154.76% | -57126.72% |
2022 | 0.27% | -100.48% |
2021 | -56.34% | -13.14% |
2020 | -64.86% | 71.29% |
2019 | -37.87% | 28.87% |
2018 | -29.38% | -3.68% |
2017 | -30.51% | -137.50% |
The current ROE of Homology Medicines, Inc. (FIXX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-70.28%
5-year avg
-62.71%
10-year avg
-36.51%
Homology Medicines, Inc.’s ROE is less than Passage Bio, Inc. (0%), greater than Stoke Therapeutics, Inc. (-72.53%), greater than Atreca, Inc. (-54.45%), greater than TCR2 Therapeutics Inc. (-199.88%), greater than Adaptimmune Therapeutics plc (-71.90%), greater than Black Diamond Therapeutics, Inc. (-74.84%), greater than Harpoon Therapeutics, Inc. (-68.08%), greater than 4D Molecular Therapeutics, Inc. (-19.66%), greater than null (-28.00%),
Company | ROE | Market cap |
---|---|---|
0% | $40.03M | |
-72.53% | $614.95M | |
-54.45% | $3.57M | |
-199.88% | $58.11M | |
-71.90% | $150.46M | |
-74.84% | $123.92M | |
-68.08% | $865.08M | |
-19.66% | $271.82M | |
-28.00% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Homology Medicines, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Homology Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Homology Medicines, Inc.'s ROE?
How is the ROE calculated for Homology Medicines, Inc. (FIXX)?
What is the highest ROE for Homology Medicines, Inc. (FIXX)?
What is the 3-year average ROE for Homology Medicines, Inc. (FIXX)?
What is the 5-year average ROE for Homology Medicines, Inc. (FIXX)?
How does the current ROE for Homology Medicines, Inc. (FIXX) compare to its historical average?